1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Auto-Injectors Market, By Type
5.1 Introduction
5.2 Disposable
5.3 Reusable
5.3.1 Prefilled Auto-injectors
5.3.2 Empty Auto-injectors
6 Global Auto-Injectors Market, By Route of Administration
6.1 Introduction
6.2 Subcutaneous
6.3 Intramuscular
7 Global Auto-Injectors Market, By Therapy
7.1 Introduction
7.2 Anaphylaxis
7.3 Asthma
7.4 Diabetes
7.5 Hormone Therapy
7.6 Migraine
7.7 Multiple Sclerosis
7.8 Oncology
7.9 Rheumatoid Arthritis
7.10 Other Therapies
8 Global Auto-Injectors Market, By Type of Molecule
8.1 Introduction
8.2 Monoclonal Antibody
8.3 Peptide
8.4 Protein
8.5 Small Molecule
9 Global Auto-Injectors Market, By Distribution Channel
9.1 Introduction
9.2 Hospital Pharmacies
9.3 Retail Pharmacies
9.4 Online Pharmacies
10 Global Auto-Injectors Market, By End User
10.1 Introduction
10.2 Home Care Settings
10.3 Hospitals & Clinics
10.4 Ambulatory Care Settings
11 Global Auto-Injectors Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 AbbVie Inc
13.2 Amgen Inc.
13.3 Antares Pharma
13.4 Bayer AG
13.5 Becton, Dickinson and Company
13.6 Biogen
13.7 Eli Lilly and Company
13.8 F. Hoffmann La Roche Ltd.
13.9 GlaxoSmithKline plc
13.10 Halozyme Therapeutics Inc.
13.11 Johnson & Johnson
13.12 medmix Ltd.
13.13 Merck KGaA
13.14 Owen Mumford Ltd.
13.15 Pfizer Inc.
13.16 Recipharm AB
13.17 Teva Pharmaceutical
13.18 Ypsomed
List of Tables
Table 1 Global Auto-Injectors Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Auto-Injectors Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Auto-Injectors Market Outlook, By Disposable (2021-2030) ($MN)
Table 4 Global Auto-Injectors Market Outlook, By Reusable (2021-2030) ($MN)
Table 5 Global Auto-Injectors Market Outlook, By Prefilled Auto-injectors (2021-2030) ($MN)
Table 6 Global Auto-Injectors Market Outlook, By Empty Auto-injectors (2021-2030) ($MN)
Table 7 Global Auto-Injectors Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 8 Global Auto-Injectors Market Outlook, By Subcutaneous (2021-2030) ($MN)
Table 9 Global Auto-Injectors Market Outlook, By Intramuscular (2021-2030) ($MN)
Table 10 Global Auto-Injectors Market Outlook, By Therapy (2021-2030) ($MN)
Table 11 Global Auto-Injectors Market Outlook, By Anaphylaxis (2021-2030) ($MN)
Table 12 Global Auto-Injectors Market Outlook, By Asthma (2021-2030) ($MN)
Table 13 Global Auto-Injectors Market Outlook, By Diabetes (2021-2030) ($MN)
Table 14 Global Auto-Injectors Market Outlook, By Hormone Therapy (2021-2030) ($MN)
Table 15 Global Auto-Injectors Market Outlook, By Migraine (2021-2030) ($MN)
Table 16 Global Auto-Injectors Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
Table 17 Global Auto-Injectors Market Outlook, By Oncology (2021-2030) ($MN)
Table 18 Global Auto-Injectors Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
Table 19 Global Auto-Injectors Market Outlook, By Other Therapies (2021-2030) ($MN)
Table 20 Global Auto-Injectors Market Outlook, By Type of Molecule (2021-2030) ($MN)
Table 21 Global Auto-Injectors Market Outlook, By Monoclonal Antibody (2021-2030) ($MN)
Table 22 Global Auto-Injectors Market Outlook, By Peptide (2021-2030) ($MN)
Table 23 Global Auto-Injectors Market Outlook, By Protein (2021-2030) ($MN)
Table 24 Global Auto-Injectors Market Outlook, By Small Molecule (2021-2030) ($MN)
Table 25 Global Auto-Injectors Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 26 Global Auto-Injectors Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 27 Global Auto-Injectors Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 28 Global Auto-Injectors Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 29 Global Auto-Injectors Market Outlook, By End User (2021-2030) ($MN)
Table 30 Global Auto-Injectors Market Outlook, By Home Care Settings (2021-2030) ($MN)
Table 31 Global Auto-Injectors Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 32 Global Auto-Injectors Market Outlook, By Ambulatory Care Settings (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
